Adaptive is leveraging the power of its platform to provide insights into the impact of the Omicron variant on T-cell responses. Check out the preliminary data we just released.
Preliminary data using @AdaptiveBiotech's immune medicine platform finds that greater than two thirds of the T-cell response to vaccines is on target against the #Omicron variant. New manuscript available here: https://t.co/95Ff0NB6c7
(1/6)
@matt_levine - "It will be a bit of world-building in my science-fiction finance novel set in the year 2264." Please, PLEASE say this is something you are working on! #financepunk
We’ve received @US_FDA Emergency Use Authorization for T-Detect™ COVID, the first T cell-based test to confirm recent or prior #COVID19 infection, developed in collaboration with @Microsoft: https://t.co/54mBgUEH7h
@expertsleepers@expertsleepers - oh! I had got mine used and they had some put some waveforms on it, etc. I thought that was a standard thing. I guess I will make an image and put it on GitHub for others to share... Thanks!
Hey, @EtheringtonBros - are you going to make the “How to Think when you Draw” books available on Lulu for those of us who missed the Kickstarter for them?!?
It’s official! We’ve launched immunoSEQ T-MAP COVID, our new proprietary research and data analysis service for vaccine developers! #Got2Adapt#InThisTogether
Help spread the word about our #ImmuneRACE study! We’re actively seeking participants in >20 metropolitan areas across the United States. #InThisTogether#Got2Adapt https://t.co/tHXes4RJB0
@exploreplanets@exploreplanets - are the orbital elements available for #lightsail2 yet? A couple of us who saw the launch were hoping that we could get telemetry over the holiday!
We're excited to announce that we've been awarded $4.5M from @EmpireStateDev to grow our footprint in New York!
Read the full release here: https://t.co/k5HW4xlW98 #biotech#MadeinNewYork